SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-084665
Filing Date
2014-03-05
Accepted
2014-03-05 16:48:06
Documents
4
Period of Report
2014-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d685908d8k.htm 8-K 28125
2 EX-5.1 d685908dex51.htm EX-5.1 4213
3 EX-10.1 d685908dex101.htm EX-10.1 12929
4 GRAPHIC g685908g11m57.jpg GRAPHIC 2194
  Complete submission text file 0001193125-14-084665.txt   49949
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 14669901
SIC: 2834 Pharmaceutical Preparations